Eli Lilly and Co. announced the FDA approval of Cymbalta (duloxetine HCI) June 17, 2008, for the management of fibromyalgia. This makes Cymbalta the second medication ever to be approved
for fibromyalgia, following Lyrica’s approval in June 2007. Read this article by chronicpainconnection editor, Karen.
Also check out “An Overview for the Newly Diagnosed Patient” from the National Fibromyalgia Association.
